(All fields required)
Please enter a valid email.
Please enter your name.
Julia S. Anixt, MD Pediatrician, Division of Developmental and Behavioral Pediatrics
Pediatrician, Division of Developmental and Behavioral Pediatrics
Assistant Professor, UC Department of Pediatrics
Attention deficit / hyperactivity disorder (ADHD); autism spectrum disorders (ASD); learning difficulties; developmental and behavioral issues in underserved populations; developmental outcomes in children with congenital heart disease
ADHD; use of shared decision making for the treatment of challenging behavior in children with ASD; the diagnosis and management of behavioral and mental health issues in primary care settings; access to care for underserved populations
Julia Anixt, MD, is a developmental-behavioral pediatrician conducting clinical research on attention deficit/ hyperactivity disorder (ADHD). In particular her work focuses on improving the quality of care for ADHD diagnosis and treatment for children in underserved communities and assessing the impact of parent and youth perceptions about ADHD on treatment decisions. Her research also focuses on implementing shared decision making (SDM) in the clinical setting for families of children with autism spectrum disorders (ASD) contemplating the use of medication to target challenging behaviors.
BS: Haverford College, Haverford, PA, 1996.
MD: University of Maryland School of Medicine, Baltimore, MD, 2001. Residency: Pediatrics, Yale New-Haven Hospital, New Haven, CT, 2004. Fellowship: Robert Wood Johnson Clinical Scholars Program, Johns Hopkins University, Baltimore, MD, 2006; Developmental-Behavioral Pediatrics, University of Maryland, Baltimore, MD, 2008. Certification: General Pediatrics, American Board of Pediatrics, 2004; Developmental and Behavioral Pediatrics, American Board of Pediatrics, 2011.
Froehlich TE, Delgado SV, Anixt JS. Expanding Medication Options for Pediatric ADHD. Current Psychiatry. 2013 Dec;12(12): 20-9.
Anixt JS, Copeland-Linder N, Haynie D, Cheng TL. Burden of Unmet Mental Health Needs in Assault-Injured Youths Presenting to the Emergency Department. Acad Pediatr. 2012 Mar-Apr;12(2):125-30.
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Curr Psychiatry Rep. 2011 Oct;13(5):333-44.
Lipkin PH, Anixt JS. Attention Deficit/ Hyperactivity Disorder (ADHD). In: ACP Smart Medicine [online database]. Philadelphia, American College of Physicians, 2014. Evidence-based, peer-reviewed ADHD diagnostic and treatment guidelines for American College of Physicians Smart Medicine; co-author and co-editor of ADHD module. Original publication date 2009; most recent edition 1/30/2014.
Olaniyan O, dosReis S, Garriett V, Mychailyszyn MP, Anixt J, Rowe PC, Cheng TL. Community Perspectives of Childhood Behavioral Problems and ADHD among African-American Parents. Ambul Pediatr. 2007 May-Jun;7(3):226-31.
dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R. Attitudes About Stimulant Medication for Attention-Deficit/Hyperactivity Disorder Among African American Families in an Inner City Community. J Behav Health Serv Res. 2006 Oct;33(4):423-30.
Keyser E, Peralta L, Cade T, Miller S, Anixt J. Functional Aerobic Impairment in Adolescents Seropositive for HIV: A Quasiexperimental Analysis. Arch Phys Med Rehabil. 2000 Nov;81(11):1479-84.
Interventions for children with Attention and Reading Disorders. Co-Investigator. National Institutes of Health. Dec 2009-Nov 2014. R01 HD060617.
Shared Decision Making to Improve Care and Outcomes for Children with Autism. Principal Investigator. Cincinnati Children’s Hospital Medical Center Place Outcomes Research Award. Jul 2013 - Jun 2015.
Stephen P. Becker, PhD Clinical Psychologist, Division of Behavioral Medicine and Clinical Psychology
Clinical Psychologist, Division of Behavioral Medicine and Clinical Psychology
Instructor, UC Department of Pediatrics
Attention-deficit/hyperactivity disorder (ADHD)
Stephen P. Becker, PhD, is currently a research instructor of pediatrics in the Division of Behavioral Medicine and Clinical Psychology's Center for ADHD at Cincinnati Children’s Hospital Medical Center. Dr. Becker completed his graduate training in clinical psychology at Miami University and his pre-doctoral psychology internship at Cincinnati Children's Hospital Medical Center.
Dr. Becker's research focuses on the social and academic impairments of children and adolescents with ADHD, with a particular interest in how co-occurring difficulties such as oppositional/aggressive behaviors, anxiety/depression, sluggish cognitive tempo (SCT), and sleep problems affect the functioning of youth with ADHD. He is also interested in school-based interventions for treating ADHD and related difficulties.
Dr. Becker has authored or co-authored over 50 publications on ADHD and related topics and serves on the editorial board of the Journal of Attention Disorders and the Journal of Youth and Adolescence.
BM: Taylor University, Upland, IN, 2004.
MA: Trinity International University, Deerfield, IL, 2008.
MA: Miami University, Oxford, OH, 2010.
PhD: Miami University, Oxford, OH, 2014.
Internship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2013-2014.
Becker SP. External validity of children’s self-reported sleep functioning: Associations with academic, social, and behavioral adjustment. Sleep Medicine. 2014. Epub ahead of print.
Becker SP, Langberg JM, Evans SW, Girio-Herrera E, Vaughn AJ. Differentiating anxiety and depression in relation to the social functioning of young adolescents with ADHD. J Clin Child Adolesc Psychol. 2014. Epub ahead of print.
Becker SP. Sluggish cognitive tempo and peer functioning in school-aged children: A six-month longitudinal study. Psychiatry Res. 2014 Jun 30;217(1-2):72-8.
Becker SP, Luebbe AM, Fite PJ, Stoppelbein L, Greening L. Sluggish cognitive tempo in psychiatrically hospitalized children: Factor structure and relations to internalizing symptoms, social problems, and observed behavioral dysregulation. J Abnorm Child Psychol. 2014 Jan;42(1):49-62.
Becker SP, Marshall SA, McBurnett K. Sluggish cognitive tempo in abnormal child psychology: An historical overview and introduction to the Special Section. J Abnorm Child Psychol. 2014 Jan;42(1):1-6.
Becker SP. Topical review: Sluggish cognitive tempo: Research findings and relevance for pediatric psychology. J Pediatr Psychol. 2013 Nov;38(10):1051-7.
Becker SP, McBurnett K, Hinshaw SP, Pfiffner LJ. Negative social preference in relation to internalizing symptoms among children with ADHD predominantly inattentive type: Girls fare worse than boys. J Clin Child Adolesc Psychol. 2013; 42(6):784-95.
Becker SP, Langberg JM, Vaughn AJ, Epstein JN. Clinical utility of the Vanderbilt ADHD Diagnostic Parent Rating Scale comorbidity screening scales. J Dev Behav Pediatr. 2012 Apr;33(3) 221-8.
Becker SP, Luebbe AM, Langberg JM. Co-occurring mental health problems and peer functioning among youth with attention-deficit/hyperactivity disorder: A review and recommendations for future research. Clin Child Fam Psychol Rev. 2012 Dec;15(4):279-302.
Langberg JM, Becker SP. Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder? Clin Child Fam Psychol Rev. 2012 Sep;15(3):215-33.
William B. Brinkman, MD, MEd, MSc Director of Research Section, Division of General and Community Pediatrics
Director of Research Section, Division of General and Community Pediatrics
Methods Expert, Evidence and Measures Team, James M. Anderson Center for Health Systems Excellence
Research Director, Cincinnati Pediatric Research Group
Attending Physician, Division of Hospital Medicine
Associate Professor, UC Department of Pediatrics
Dr. Brinkman researches shared decision-making between patients, parents, and clinicians to promote high value care that is evidence-based and family-centered. He collaborates to develop interventions to facilitate shared decision-making across a wide-range of clinical contexts.
Dr. Brinkman serves as director of the Research Section in the Division of General & Community Pediatrics and the research director for the Cincinnati Pediatric Research Group, a practice-based research network. He also serves as a methods expert for the James M. Anderson Center Evidence & Measures team. In this role, he is building an infrastructure to support shared decision-making throughout Cincinnati Children's.
MD: St. Louis University, St. Louis, MO, 1999.
Residency: Pediatrics, The Children's Memorial Hospital, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2002.
Chief Residency: Pediatrics, The Children's Memorial Hospital, Chicago, IL, 2003.
Fellowship: NRSA Primary Care Research Fellowship, General & Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2006.
MEd: University of Cincinnati, Cincinnati, OH, 2006.
MSc: University of Cincinnati, Cincinnati, OH, 2013.
Certification: Pediatrics, 2002.
Brady PW, Brinkman WB, Simmons JM, Yau C, White CM, Kirkendall ES, Schaffzin JK, Conway PH, Vossmeyer MT. Oral antibiotics at discharge for children with acute osteomyelitis: a rapid cycle improvement project. BMJ Qual Saf Online First. Dec 17, 2013.
Lipstein EA, Brinkman WB, Sage J, Lannon CM, Morgan DeWitt E. Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment. Pediatr Rheumatol Online J. 2013 Sep 30; 11(1):34.
Brinkman WB, Hartl Majcher J, Poling L, Shi G, Zender M, Sucharew H, Britto MT, Epstein JN. Shared Decision-Making to Improve Attention-Deficit/Hyperactivity Disorder Care. Patient Educ Couns. 93 (2013) 95–101.
Jerardi KE, Elkeeb D, Weiser J, Brinkman WB. Rapid Implementation of Evidence Based Guidelines for Imaging after First Urinary Tract Infection. Pediatrics. 2013;132:e749–e755.
Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF. In their own words: Adolescent views on ADHD and their evolving role managing medication. Acad Pediatr. 2012 Jan; 12(1):53-61.
Brinkman WB, Hartl J, Rawe L, Sucharew H, Britto MT, Epstein JN. Physicians’ Shared Decision Making Behaviors in Attention-Deficit/Hyperactivity Disorder Care. Arch Pediatr Adolesc Med. 2011 Nov; 165(11):1013-9.
Lipstein EA, Brinkman WB, Britto MT. What Is Known about Parent’s Treatment Decisions? A Narrative Review of Pediatric Decision Making. Med Decis Making. 2012 Mar-Apr;32(2):246-58.
Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF. Parental Angst Making and Revisiting ADHD Treatment Decisions. Pediatrics. 2009 Aug; 124: 580-9.
Brinkman WB, Geraghty SR, Lanphear BP, Khoury JC, Gonzalez del Rey JA, DeWitt TG, Britto MT. Effect of Multi-Source Feedback on Resident Communication Skills and Professionalism. A Randomized Controlled Trial. Arch Pediatr Adolesc Med. 2007 Jan; 161: 44-9.
Brinkman WB, Geraghty SR, Lanphear BP, Khoury JC, Gonzalez del Rey JA, DeWitt TG, Britto MT. Evaluation of Resident Communication Skills and Professionalism: A Matter of Perspective?Pediatrics. 2006 Oct; 18: 1371-9.
Medication Continuity in Children Treated for ADHD. Principal Investigator. Mentored Patient-Oriented Research Career Development Award, National Institute of Mental Health. Jan 2010–Nov 2014.
Developing New Technologies to Improve ADHD Medication Continuity. R34, National Institute of Mental Health. Apr 2014–Mar 2017.
Shared Decision Making to Improve Care and Outcomes for Children with Autism. Co-Principal Investigator. Cincinnati Children’s Place Research Outcomes Award. Jul 2013 – Jun 2015.
Testing and Spread of Shared Decision Making Tools across Learning Networks. Co-Principal Investigator. Subproject on Agency for Healthcare Research and Quality Cincinnati Children’s Center for Education and Research on Therapeutics (CERTs). Sep 2013-Aug 2015.
Partnering with Parents to Support Decision-Making About Hydroxyurea in Pediatric Sickle Cell Disease. Co-Principal Investigator. Subproject on Agency for Healthcare Research and Quality Cincinnati Children’s Center for Education and Research on Therapeutics (CERTs). Sep 2013-Aug 2015.
Evaluation of an Intervention for Improving Community-Based Pediatric ADHD Care. (PI: Epstein) Co-Investigator. National Institute of Mental Health. Aug 2010-May 2015.
Collaborative Ohio Inquiry Networks (COIN) Research Center. (PI: Werner) Co-investigator. Agency for Healthcare Research and Quality. Sep 2012-Aug 2017.
Jeffrey N. Epstein, PhD Director, Center for ADHD, Behavioral Medicine and Clinical Psychology
Director, Center for ADHD, Behavioral Medicine and Clinical Psychology
Clinical Psychologist, Behavioral Medicine and Clinical Psychology
Professor, UC Department of Pediatrics
Attention deficit hyperactivity disorder (ADHD)
Jeff Epstein, PhD, is a professor of pediatrics in Behavioral Medicine and Clinical Psychology at Cincinnati Children's Hospital Medical Center. He earned his doctorate in clinical psychology from State University of New York at Stony Brook and completed a clinical internship at the Medical University of South Carolina.
Dr. Epstein is a licensed psychologist whose research and clinical work focus on the diagnosis and treatment of ADHD and other psychological disorders originating in childhood.
He is a co-investigator on the Multimodal Treatment Study of Children with ADHD (MTA). Dr. Epstein has published numerous empirical papers on a variety of ADHD-related topics. Much of his empirical research has concentrated on the neuropsychology of ADHD, and the promotion of evidence-based ADHD care among community pediatricians.
Epstein JN. How can the internet help improve community-based pediatric ADHD care? Expert Review of Neurotherapeutics. 2012;12, 501-503.
Becker SP, Langberg JM, Vaughn AJ, Epstein JN. Clinical utility of the Vanderbilt ADHD Diagnostic Parent Rating Scale comorbidity screening scales. Journal of Developmental and Behavioral Pediatrics. 2012;33, 221-228.
Shiels K, Tamm L, Epstein JN. Deficient post-error slowing in children with ADHD is limited to the inattentive subtype. Journal of the International Neuropsychological Society. 2012;18, 1-6.
Froehlich TE, Epstein JN, Nick TG, Melguizo-Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. Pharmacogenetic predictors of methylphenidate dose-response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;50, 1129-1139.
Brinkman WB, Hartl J, Rawe L, Britto MT, Epstein JN. Physicians’ shared decision making behaviors in Attention-Deficit/Hyperactivity Disorder care. Archives of Pediatrics and Adolescent Medicine. 2011;165, 1013-1019.
Vaughn A, Epstein J, Rausch J, Altaye M, Langberg J, Newcorn J, Hinshaw S, Hechtman L, Arnold LE, Swanson J, Wigal T. Relations between neuropsychological functioning and ADHD symptomatology over time. Journal of Abnormal Child Psychology. 2011;39, 853-864
Epstein JN, Langberg JM, Rosen PJ, Graham A, Narad ME, Antonini TN, Brinkman WB, Froehlich T, Simon JO, Altaye M. Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations. Neuropsychology. 2011;25, 427-441.
Epstein JN, Langberg JM, Lichtenstein PK, Kolb R, Altaye M, Simon JO. Use of a web portal to improve community-based pediatric ADHD care: A cluster randomized trial. Pediatrics. 2011;128, e1201-e1208.
Langberg JM, Molina BSG, Arnold LE, Epstein JN, Altaye M, Hinshaw SP, Swanson JM, Wigal T, Hechtman L. Patterns and predictors of adolescent academic achievement and performance in a sample of children with Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of Clinical Child and Adolescent Psychology. 2011;40, 1-13.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology. 2011;36, 1060-1072.
Tanya Elizabeth Froehlich, MD, MS, FAAP
Dr. Froehlich is a developmental-behavioral pediatrician who cares for school age children with learning and behavioral issues. Her research has a special focus on attention-deficit/hyperactivity disorder (ADHD), and approaches the disorder from the vantage points of epidemiology, etiology, and treatment. She conducted a study reporting the national prevalence of ADHD in U.S. children based on DSM-IV criteria (published in the Archives of Pediatrics and Adolescent Medicine) which showed that children from disadvantaged socioeconomic backgrounds were most likely to meet criteria for ADHD, yet least likely to receive consistent ADHD pharmacotherapy. Interested in understanding why certain children (including those with low socioeconomic status) may be more vulnerable to ADHD than others, she also studies the contribution of environmental exposures to ADHD and their public health impact. In Pediatrics, she published the first study to investigate the interactive effects of prenatal tobacco exposure and childhood lead exposure on ADHD and demonstrated that the association between poverty and ADHD is partially explained by the effects of these common environmental toxicants. She has also examined possible gene-environment interactions and found that boys with specific dopamine-related genetic variants were particularly susceptible to the adverse effects of lead exposure on ADHD-related executive functioning (published in Biological Psychiatry). Dr. Froehlich continues to research environmental influences on ADHD as a co-investigator on a National Institute of Environmental Health Sciences R01 grant which is examining the effects of pyrethroid pesticide exposure on ADHD symptoms and executive functioning.
Dr. Froehlich’s research agenda also addresses ADHD treatment. She is the recipient of a National Institute of Mental Health K23 Award aimed at identifying genetic and phenotypic predictors of ADHD medication response. Recently, she authored a paper in the Journal of the American Academy of Child and Adolescent Psychiatry showing that individuals with the dopamine receptor D4 and dopamine transporter genotypes believed to confer lower susceptibility to ADHD had greater improvement in their hyperactive-impulsive symptoms with methylphenidate treatment than those with the “high risk” genetic variants. She also coauthored a study on a novel genotyping assay for carboxylesterase 1 (CES1), the enzyme which metabolizes methylphenidate, and is currently undertaking a study on CES1 genetic variants’ effects on methylphenidate response.
Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities. She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums. Currently, Dr. Froehlich co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and coordinates ADHD-related projects and educational seminars for the Society membership in this capacity.
BA: East Asian Studies, Columbia University, 1992.
MD: Yale University School of Medicine, 1999.
MS: Epidemiology, University of Cincinnati, 2007.
Pediatric Intern: Children’s Hospital of Philadelphia, 1999-2000.
Pediatric Resident: Children’s Hospital of Philadelphia, 2000-2002.
Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital, 2002-2005; General Pediatrics National Research Service Award Fellow, Cincinnati Children’s Hospital, 2004-2007.
Zhu HJ, Brinda B, Froehlich TE, Markowitz JS. A Discriminative Analytical Method for Detection of CES1A1 and CES1A2/CES1A3 Genetic Variants. Pharmacogenetics and Genomics. 2012; 22(3): 215-218.
Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;11:1129-1139.
Froehlich TE, Anixt J, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman R. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports. 2011;13(5):333-44.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology. 2011; 36(5): 1060-1072.
Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein, JN. Clinical utility of the Vanderbilt ADHD rating scale for identifying children without comorbid learning disorders. Pediatrics. 2010; 126: e1033-e1038.
Froehlich TE, McGough JJ, Stein MA. Progress and Promise of ADHD Pharmacogenetics. CNS Drugs. 2010; 24: 99-117.
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS. The Association of Tobacco and Lead Exposure with Attention-Deficit/Hyperactivity Disorder in a National Sample of U.S. Children. Pediatrics. 2009; 124: e1054-63.
Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing Children with ADHD in Primary Care Settings. Expert Rev Neurother. 2008; 8: 627-41.
Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence and Treatment of ADHD in a National Sample of U.S. Children. Archives of Pediatrics and Adolescent Medicine. 2007;161(9): 857-864.
Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. Interactive Effects of a DRD4 Polymorphism, Lead, and Sex on Executive Functions in Children. Biological Psychiatry. 2007; 62: 243-249.
Nicholas Newman, DO, MS, FAAP Physician, Division of General and Community Pediatrics
Physician, Division of General and Community Pediatrics
Medical Director, Pediatric Environmental Health and Lead Clinic
Pediatric Primary Care Center
Nicholas Newman, DO, MS, FAAP, is board certified in general pediatrics as well as occupational/environmental medicine. He is interested understanding how toxicants in and around a child’s home or school can affect children's health. He is also interested in developing approaches to prevent or mitigate these effects at an individual and at a community level. His recent research has examined the effect of traffic related air pollution exposure on neurobehavioral problems in children as well as the impact of air pollution on asthma in children.
BS: Massachusetts Institute of Technology, Cambridge, MA, 1990.
DO: Kirksville College of Osteopathic Medicine, Kirksville, MO, 1997.
Rotating Internship: Horizon Health System/Henry Ford Health System, Michigan State University, Detroit, MI, 1998.
Residency: Pediatrics, Children’s Hospital of Michigan, Wayne State University, Detroit, MI, 2001.
Fellowship: Occupational and Environmental Medicine, University of Cincinnati, Cincinnati, OH, 2011.
MS: University of Cincinnati, Department of Environmental Health, Cincinnati, OH, 2011.
Certification: American Board of Pediatrics, 2001 (renewed 2008); American Board of Preventive Medicine, 2013
Beck AF, Huang B, Simmons JM, Moncrief T, Sauers HS, Ryan PH, Newman NC, Kahn RS. Role of Financial and Social Hardships in Asthma Racial Disparities. Pediatrics. 2014 Feb 2 [Epub ahead of print].
Newman NC, Ryan P, Lemasters G, Levin L, Bernstein D, Hershey GK, et al. Traffic-related air pollution exposure in the first year of life and behavioral scores at 7 years of age. Environ Health Perspect. 2013 Jun;121(6):731-6.
Genter M, Newman N, Shertzer H, Syed A, Bolon B. Distribution and Systemic Effects of Intranasally Administered 25 nm Silver Nanoparticles in Adult Mice. Toxicol Pathol. May 4, 2012, 00:10-10, 2012.
Hudson N, Calvert G, Newman N, et al. Acute Illnesses Associated with Insecticides used to Control Bed Bugs --- Seven States 2003-2010. MMWR. Sep 23, 2011 / 60(37);1269-1274.
L Trasande, NC Newman, L Long, G Howe, BJ Kerwin, RJ Martin, SA Gahagan, WB Weil. Translating Knowledge About Environmental Health to Practitioners: Are We Doing Enough?Mount Sinai Journal of Medicine. 77:114-123, 2010.
Health Care Provider Training. Principal Investigator. National Environmental Education Foundation (NEEF). 08/01/2012─08/31/2014.
Great Lakes Center for Env Health at John H Stroger Hospital. Principal Investigator. Pediatric Environmental Health Specialty Units (PEHSU). 1/2012–9/30/2014.
Reading ICARD: Interventions for Children with Attention Deficit Disorders. Co-Investigator. National Institute of Health/NICHE. Denton/Tamm. 4/1/2010–2/28/15. R01HD060617–04.
Neurobehavior and Neuroimaging Effects of Traffic Exposure in Children. Co-Investigator. National Institute of Environmental Health Sciences. Ryan. 07/01/2012–06/30/2016. R01ES019890.
Center for Environmental Genetics-Community Outreach and Engagement Core. Principal Investigator. National Institute for Environmental Health, University of Cincinnati. Ho. 04/01/2013-03/31/2018. P30-ES006096.
Environmental Exposures and their role in developmental diseases. Principal Investigator. National Institute for Environmental Health, University of Cincinnati. Haynes. 07/09/2012-06/30/2014. R21ES02116-01A1.
Suzanne R. Plummer, PsyD Staff Psychologist, Behavioral Medicine and Clinical Psychology, Center for ADHD
Staff Psychologist, Behavioral Medicine and Clinical Psychology, Center for ADHD
ADHD; anxiety; depression; behavior disorders
Leanne Tamm, PhD Clinical Psychologist, Behavioral Medicine and Clinical Psychology
ADHD; ADHD subtypes; non-medication interventions; early intervention and prevention; treatment outcomes; brain-behavior relationships; gene-environment interactions; motivation
Tamm L, Hughes C, Ames L, Pickering J, Silver CH, Stavinoha P, Castillo CL, Rintelmann J, Moore J, Foxwell A, Bolanos SG, Hines T, Nakonezny PA, Emslie G. Attention training for school-aged children with ADHD: results of an open trial. J Atten Disord. 2010 Jul;14(1):86-94.
Lakes, KD, Kettler, RJ, Schmidt, J, Haynes, M, Feeney-Kettler, K, Swanson, JM, & Tamm, L. The CUIDAR Early Intervention Parent Training Program for Preschoolers at Risk for Behavioral Disorders: An Innovative Practice for Reducing Disparities in Access to Service. Journal of Early Intervention. 2009;31:167-78.Tamm L, Carlson CL. Task demands interact with the single and combined effects of medication and contingencies on children with ADHD. J Atten Disord. 2007 May;10(4):372-80.
Tamm L, Menon V, Reiss AL. Parietal attentional system aberrations during target detection in adolescents with attention deficit hyperactivity disorder: event-related fMRI evidence. Am J Psychiatry. 2006 Jun;163(6):1033-43.
Tamm L, Swanson JM, Lerner MA, Childress C, Patterson B, Lakes KD, Nguyen A, Kudo M, Altamirano W, Miller J, Santoyo R, Camarero-Morse V, Watkins JM, Simpson S, Waffarn F, Cunningham C. Intervention for preschoolers at risk for attention-deficit/hyperactivity disorder (ADHD): service before diagnosis. Clin Neurosci Res. 2005;5:247-253.
Tamm L. Attention Deficit Hyperactivity Disorder. In New Encyclopedia of Neuroscience, L.R. Squire (Ed.). Oxford: Academic Press, 2009.
Tamm L, McCandliss BD, Liang A, Wigal TL, Posner, MI, Swanson, JM. Can attention itself be trained? Attention training for children at risk for ADHD. In Attention Deficit/Hyperactivity Disorder: Concepts, Controversies, New Directions, Medical Psychiatry Series. Vol. 37. New York: Informa Healthcare, 2007.
Aaron J. Vaughn, PhD Associate Training Director, O’Grady Residency
Associate Training Director, O’Grady Residency
Center for ADHD
Aaron Vaughn, PhD, is an assistant professor of pediatrics in Behavioral Medicine and Clinical Psychology at Cincinnati Children's Hospital Medical Center. He earned his MS in clinical psychology from Purdue University, a doctorate in clinical psychology from University of Vermont and completed a clinical internship and postdoctoral fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Vaughn specializes in the assessment and behavioral management of children and adolescents with attention-deficit / hyperactivity disorder and related conditions.
Research interests include the assessment and treatment of ADHD including better understanding of the social, academic, and behavioral impairments exhibited by children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) from a developmental psychopathology perspective. Dr. Vaughn’s research is targeted in applying what is learned toward increasing the effectiveness of evidence-based treatments for children and adolescents with ADHD.
In particular, Dr. Vaughn’s research is concentrated around:
BA: Cedarville University.
MS: Clinical Psychology, Purdue University.
PhD: Clinical Psychology, University of Vermont.
Predoctoral Internship: Cincinnati Children's Hospital Medical Center, 2008-2009.
Postdoctoral Fellowship: Cincinnati Children's Hospital Medical Center, 2009-2011.
Hoza B, Vaughn A, Waschbusch DA, Murray-Close D, McCabe G. Can children with ADHD be motivated to reduce bias in self-reports of competence?Journal of Consulting & Clinical Psychology. 2012;80, 245-254.
Vaughn AJ, Hoza B. The incremental utility of rating scales and a structured diagnostic interview in the assessment of ADHD. Journal of Emotional and Behavioral Disorders. 2012.
Zelaznik H, Vaughn A, Smith A, Hoza B, Green J, Linnea K. Timing deficits in children with Attention Deficit/Hyperactivity Disorder. Human Movement Science. 2012. 31, 255-265.
McQuade JD, Vaughn AJ, Hoza B, Murray-Close D, Molina BSG, Arnold LE, Hechtman L. Perceived social acceptance and peer status differentially predict adjustment in youth with and without ADHD. Journal of Attention Disorders. 2012.
Langberg JM, Becker SP, Epstein JN, Vaughn AJ, Girio-Herrera E. Predictors of response and mechanisms of change in an organizational skills intervention for students with ADHD. Journal of Child and Family Studies. 2012.
Langberg JM, Epstein JN, Becker SP, Girio-Herrera E, Vaughn AJ. Evaluation of the Homework, Organization, and Planning Skills (HOPS) intervention for middle school students with ADHD as implemented by school mental health providers. School Psychology Review. 2012;42, 342-364.
Vaughn AJ, Epstein J, Rausch J, Altaye M, Langberg J, Newcorn J, Hinshaw S, Hechtman L, Arnold LE, Swanson J, Wigal T. Relations between outcomes on a continuous performance test and ADHD symptoms over time. Journal of Abnormal Child Psychology. 2011. 39, 853-864.
Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein JN. Clinical utility of the Vanderbilt ADHD rating scale for identifying children without comorbid learning disorders. Pediatrics. 2010;126, 1033-1038.
2/2 Multisite Study of School Based Treatment Approaches for ADHD Adolescents. Co-Investigator (Principal Investigator, Langberg). National Institute of Mental Health (NIMH). July 2009-June 2014. R01.
Evaluation of an Intervention for Improving Community-Based Pediatric ADHD Care. Co-Investigator (Principal Investigator, Epstein). National Institute of Mental Health (NIMH). July 2010-June 2015. R01.
Reading ICARD: Interventions for Children with Attention and Reading Disorders. Co-Investigator (Principal Investigator, Denton). NICHD. R01.
Disseminating a Model Intervention to Promote Improved ADHD Care in the Community. Co-Investigator (Principal Investigator, Epstein). National Institute of Mental Health (NIMH). July 2010-June 2015. R21.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center